March 16th, 2010 by GruntDoc in Better Health Network, News, Opinion
Tags: Accelerator, Accidents, Cars, Emergency Medicine, Prius, Safety, Speeding
No Comments »
I have a confession: I’ve been risking my life.
Yes, still driving a Prius.
I do buy that accelerator pedals can be mechanically jammed by a floor mat (though there’s clips on my car to hold it in place), but this unintended acceleration ‘panic’ is just that. (If for no other reason that there’s now a flurry of cases of this, and none before it was the freak-out du jour). Read more »
*This blog post was originally published at GruntDoc*
March 14th, 2010 by Berci in Better Health Network, News, True Stories
Tags: Gastroenterology, New York Times, Pancreatitis, Pediatrics, Social Media, Twitter
No Comments »
I have many reasons to use Twitter. One of them is that it’s quite easy to get feedback from doctors who also use Twitter for communication. Now one of my stories was featured in the New York Times.
Some people are even using Twitter for more urgent questions. Bertalan Meskó, a medical student at the University of Debrecen in Hungary, wrote a post about a patient with mysterious symptoms: “Strange case today in internal medicine rotation. 16 years old boy with acute pancreatitis (for the 6th! time). Any ideas?”
Within hours, specialists worldwide had responded, suggesting gallstones, lupus or growths on the pancreas. One of the suggestions helped the doctors with a diagnosis.
“It would have been impossible to find that specialist through e-mail, because we had no idea who to contact,” Mr. Meskó said.
*This blog post was originally published at ScienceRoll*
March 12th, 2010 by Medgadget in Better Health Network, Health Tips, News
Tags: breath test, Diagnosis, Infectious Disease, mycobacteria, tb, Technology, tuberculosis
1 Comment »
Menssana Research, Inc is touting results from a trial testing its Breathscanner for diagnosing patients with active pulmonary tuberculosis. Menssana has developed technology that may bring breath testing for a variety of conditions, including the already FDA approved breath test for heart transplant rejection.
Some details about the technology from Menssana:
The Mycobacteria that cause pulmonary TB generate a very distinctive pattern of volatile organic compounds (VOCs) when grown in the laboratory. If these VOCs could also be detected in the breath of infected patients, it might provide a new method for detecting active infection with pulmonary TB. Read more »
*This blog post was originally published at Medgadget*
March 12th, 2010 by StaceyButterfield in Better Health Network, News
Tags: AHRQ, Carolyn Clancy, Chasm, Clinical, Comparative Effectiveness, Healthcare reform, Quality, Research
No Comments »
As one would expect from such a diverse group, comparisons were a common topic at the co-located National Medical Home Summit, National Retail Clinic Summit, and Population Health and Disease Management Colloquium this week.
During an opening session, Carolyn Clancy, head of the AHRQ, updated us on some of the comparison work her agency has been doing. Last year’s stimulus bill dedicated a lot of funds ($300 mill directly, more through the Secretary of HHS) to the agency’s work on comparative effectiveness. Read more »
*This blog post was originally published at ACP Internist*
March 11th, 2010 by Jonathan Foulds, Ph.D. in Better Health Network, News, Opinion
Tags: addiction, Addiction Medicine, Cigarettes, FDA, nicotine, Nicotine-Free, Quitting, Regulation, smoking, smoking cessation
No Comments »
In the previous posting I discussed the possibility of FDA requiring that no tobacco products be allowed to emit Carbon Monoxide. While appealing in its simplicity, such a strategy may have problems in that it could be interpreted as a ban on a whole class (or classes) of tobacco products, which the legislation does not allow.
Another strategy might be to reduce the harm from tobacco by lowering the nicotine content/delivery of cigarettes down to the level at which they are no longer addictive. A form of this strategy was proposed in the 1990’s by leading tobacco researchers Professor Neal Benowitz, and Professor Jack Henningfield. The FDA legislation singles out nicotine as the only chemical that cannot be reduced to zero, but this allows FDA the right to reduce the nicotine delivery of tobacco products down to a level just above zero at which they would no longer be addictive. Read more »
This post, Will Nicotine-Free Cigarettes Be Mandated By The FDA?, was originally published on
Healthine.com by Jonathan Foulds, Ph.D..
